{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T14:28:07Z","timestamp":1768314487161,"version":"3.49.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100017346","name":"Boehringer Ingelheim Japan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017346","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Investigation"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.resinv.2025.07.014","type":"journal-article","created":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T19:00:42Z","timestamp":1754161242000},"page":"955-963","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Ability of patient-reported outcomes to predict progression-free survival in patients with mild to moderate fibrosing interstitial lung disease"],"prefix":"10.1016","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9298-3504","authenticated-orcid":false,"given":"Masaki","family":"Okamoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2212-0631","authenticated-orcid":false,"given":"Toyoshi","family":"Yanagihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2274-4599","authenticated-orcid":false,"given":"Yoshiaki","family":"Zaizen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8681-7588","authenticated-orcid":false,"given":"Kiminori","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6519-3446","authenticated-orcid":false,"given":"Tomonori","family":"Chikasue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4830-4033","authenticated-orcid":false,"given":"Akiko","family":"Sumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4524-4813","authenticated-orcid":false,"given":"Kazuhiro","family":"Tabata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Tominaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norikazu","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Nouno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuji","family":"Matsuura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenta","family":"Hamasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Kawaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoaki","family":"Hoshino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.resinv.2025.07.014_bib1","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","article-title":"Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS\/ERS\/JRS\/ALAT clinical practice guideline","volume":"205","author":"Raghu","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2025.07.014_bib2","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","article-title":"An official American Thoracic Society\/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias","volume":"188","author":"Travis","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2025.07.014_bib3","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1164\/rccm.201403-0566OC","article-title":"Epidemiologic survey of Japanese patients with idiopathic pulmonary fibrosis and investigation of ethnic differences","volume":"190","author":"Natsuizaka","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2025.07.014_bib4","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1164\/rccm.202205-0910LE","article-title":"Patient characteristics and survival for progressive pulmonary fibrosis using different definitions","volume":"207","author":"Khor","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2025.07.014_bib5","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1164\/rccm.200703-463PP","article-title":"Idiopathic pulmonary fibrosis clinical research network investigators. Acute exacerbations of idiopathic pulmonary fibrosis","volume":"176","author":"Collard","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2025.07.014_bib6","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","article-title":"Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis","volume":"370","author":"Richeldi","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2025.07.014_bib7","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1056\/NEJMoa1402582","article-title":"A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis","volume":"370","author":"King","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2025.07.014_bib8","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1056\/NEJMoa1908681","article-title":"Nintedanib in progressive fibrosing interstitial lung diseases","volume":"381","author":"Flaherty","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2025.07.014_bib9","doi-asserted-by":"crossref","first-page":"684","DOI":"10.7326\/0003-4819-156-10-201205150-00004","article-title":"A multidimensional index and staging system for idiopathic pulmonary fibrosis","volume":"156","author":"Ley","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.resinv.2025.07.014_bib10","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1378\/chest.13-1474","article-title":"Predicting survival across chronic interstitial lung disease: the ILD-GAP model","volume":"145","author":"Ryerson","year":"2014","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2025.07.014_bib11","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1111\/resp.13138","article-title":"Disease severity staging system for idiopathic pulmonary fibrosis in Japan","volume":"22","author":"Kondoh","year":"2017","journal-title":"Respirology"},{"key":"10.1016\/j.resinv.2025.07.014_bib12","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.resinv.2024.12.005","article-title":"Predictive factors of progression in mild fibrosing interstitial lung disease patients with gender-age-physiology score of 3 or less","volume":"63","author":"Okamoto","year":"2025","journal-title":"Respir Investig"},{"key":"10.1016\/j.resinv.2025.07.014_bib13","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1183\/09031936.00152609","article-title":"A simple assessment of dyspnoea as a prognostic indicator in idiopathic pulmonary fibrosis","volume":"36","author":"Nishiyama","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2025.07.014_bib14","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1164\/rccm.200604-520OC","article-title":"Six-minute-walk distance predicts waiting list survival in idiopathic pulmonary fibrosis","volume":"174","author":"Lederer","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2025.07.014_bib15","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1513\/AnnalsATS.201807-443OC","article-title":"Computed tomography honeycombing identifies a progressive fibrotic phenotype with increased mortality across diverse interstitial lung diseases","volume":"16","author":"Adegunsoye","year":"2019","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.resinv.2025.07.014_bib16","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.resinv.2016.02.009","article-title":"Validation of the Japanese disease severity classification and the GAP model in Japanese patients with idiopathic pulmonary fibrosis","volume":"54","author":"Kondoh","year":"2016","journal-title":"Respir Investig"},{"key":"10.1016\/j.resinv.2025.07.014_bib17","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1378\/chest.14-0453","article-title":"Validation of the GAP score in Korean patients with idiopathic pulmonary fibrosis","volume":"147","author":"Kim","year":"2015","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2025.07.014_bib18","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00255-2018","article-title":"African-American race and mortality in interstitial lung disease: a multicentre propensity-matched analysis","volume":"51","author":"Adegunsoye","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2025.07.014_bib19","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1164\/rccm.201309-1634ST","article-title":"An official American thoracic society\/European respiratory society statement: key concepts and advances in pulmonary rehabilitation","volume":"188","author":"Spruit","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2025.07.014_bib20","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1097\/MCP.0b013e328363f479","article-title":"Health-related quality of life in idiopathic pulmonary fibrosis: where are we now?","volume":"19","author":"Belkin","year":"2013","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.resinv.2025.07.014_bib21","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1378\/chest.116.5.1175","article-title":"Assessment of health-related quality of life in patients with interstitial lung disease","volume":"116","author":"Chang","year":"1999","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2025.07.014_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12931-017-0621-y","article-title":"Health related quality of life in patients with idiopathic pulmonary fibrosis in clinical practice: insights-IPF registry","volume":"18","author":"Kreuter","year":"2017","journal-title":"Respir Res"},{"key":"10.1016\/j.resinv.2025.07.014_bib23","doi-asserted-by":"crossref","DOI":"10.1111\/resp.13293","article-title":"Performance of the St George's Respiratory Questionnaire in patients with connective tissue disease-associated interstitial lung disease","author":"Suzuki","year":"2018","journal-title":"Respirology"},{"key":"10.1016\/j.resinv.2025.07.014_bib24","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12931-017-0503-3","article-title":"The St. George's Respiratory Questionnaire as a prognostic factor in IPF","volume":"18","author":"Furukawa","year":"2017","journal-title":"Respir Res"},{"key":"10.1016\/j.resinv.2025.07.014_bib25","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/resp.12936","article-title":"COPD Assessment Test for measurement of health status in patients with idiopathic pulmonary fibrosis: a cross-sectional study","volume":"22","author":"Matsuda","year":"2017","journal-title":"Respirology"},{"key":"10.1016\/j.resinv.2025.07.014_bib26","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.resinv.2024.08.006","article-title":"Responsiveness and minimal clinically important difference of the COPD Assessment Test in fibrotic interstitial lung disease","volume":"62","author":"Matsuda","year":"2024","journal-title":"Respir Investig"},{"key":"10.1016\/j.resinv.2025.07.014_bib27","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"2013 Classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against rheumatism collaborative initiative","volume":"65","author":"van den Hoogen","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.resinv.2025.07.014_bib28","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis (first of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2025.07.014_bib29","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League against Rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.resinv.2025.07.014_bib30","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/annrheumdis-2016-210571","article-title":"2016 American College of Rheumatology\/European League against Rheumatism classification criteria for primary Sjogren's syndrome: a consensus and data-driven methodology involving three international patient cohorts","volume":"76","author":"Shiboski","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.resinv.2025.07.014_bib31","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1002\/art.41773","article-title":"2021 American college of rheumatology\/vasculitis foundation guideline for the management of antineutrophil cytoplasmic antibody-associated vasculitis","volume":"73","author":"Chung","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.resinv.2025.07.014_bib32","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1164\/rccm.202005-2032ST","article-title":"Diagnosis of hypersensitivity pneumonitis in adults. An official ATS\/JRS\/ALAT clinical practice guideline","volume":"202","author":"Raghu","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2025.07.014_bib33","doi-asserted-by":"crossref","first-page":"7865","DOI":"10.3390\/jcm13247865","article-title":"Exercise-induced oxygen desaturation and outcomes after nintedanib therapy for fibrosing interstitial lung disease in patients without dyspnea","volume":"13","author":"Okamoto","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.resinv.2025.07.014_bib34","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0895-4356(98)00095-X","article-title":"Translation, adaptation, and validation of the SF-36 Health Survey for use in Japan","volume":"51","author":"Fukuhara","year":"1998","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.resinv.2025.07.014_bib35","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.2169\/internalmedicine.46.6218","article-title":"Health-related quality of life in patients with idiopathic pulmonary fibrosis-cross-sectional and longitudinal study","volume":"46","author":"Tomioka","year":"2007","journal-title":"Intern Med"},{"key":"10.1016\/j.resinv.2025.07.014_bib36","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12931-019-1010-5","article-title":"Psychometric properties and minimal important differences of SF-36 in Idiopathic Pulmonary Fibrosis","volume":"20","author":"Witt","year":"2019","journal-title":"Clinical Trial Respir Res"},{"key":"10.1016\/j.resinv.2025.07.014_bib37","first-page":"67","article-title":"Characteristics of physical activity and factors associated with physical activity in patients with interstitial lung disease","volume":"34","author":"Kaibe","year":"2021","journal-title":"Health Sci Res"},{"key":"10.1016\/j.resinv.2025.07.014_bib38","article-title":"Clinical impact of depression and anxiety in patients with idiopathic pulmonary fibrosis","volume":"12","author":"Lee","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.resinv.2025.07.014_bib39","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1111\/resp.12360","article-title":"Dyspnoea and comorbidity contribute to anxiety and depression in interstitial lung disease","volume":"19","author":"Holland","year":"2014","journal-title":"Respirology"},{"key":"10.1016\/j.resinv.2025.07.014_bib40","article-title":"Assessment of quality of life in IPF Patients: a multicenter observational study","volume":"41","author":"Uzer","year":"2024","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.resinv.2025.07.014_bib41","doi-asserted-by":"crossref","first-page":"564","DOI":"10.21037\/jtd-24-1631","article-title":"Association of sarcopenia with basic activities of daily living and dyspnea-related limitations in patients with interstitial lung disease","volume":"17","author":"Taketa","year":"2025","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.resinv.2025.07.014_bib42","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-98161-y","article-title":"Combined assessment of the GAP index and body mass index at antifibrotic therapy initiation for prognosis of idiopathic pulmonary fibrosis","volume":"11","author":"Suzuki","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.resinv.2025.07.014_bib43","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S2213-2600(19)30255-3","article-title":"Biomarkers of extracellular matrix turnover in patients with idiopathic pulmonary fibrosis given nintedanib (INMARK study): a randomized, placebo-controlled study","volume":"7","author":"Maher","year":"2019","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.resinv.2025.07.014_bib44","doi-asserted-by":"crossref","first-page":"5536","DOI":"10.1007\/s12325-023-02668-x","article-title":"Effect of nintedanib in patients with progressive pulmonary fibrosis in subgroups with differing baseline characteristics","volume":"40","author":"Kolb","year":"2023","journal-title":"Adv Ther"},{"key":"10.1016\/j.resinv.2025.07.014_bib45","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/resp.14154","article-title":"Idiopathic pulmonary fibrosis: physician and patient perspectives on the pathway to care from symptom recognition to diagnosis and disease burden","volume":"27","author":"Lancaster","year":"2022","journal-title":"Respirology"}],"container-title":["Respiratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534525001157?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534525001157?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T22:49:36Z","timestamp":1762382976000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212534525001157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S2212534525001157"],"URL":"https:\/\/doi.org\/10.1016\/j.resinv.2025.07.014","relation":{},"ISSN":["2212-5345"],"issn-type":[{"value":"2212-5345","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ability of patient-reported outcomes to predict progression-free survival in patients with mild to moderate fibrosing interstitial lung disease","name":"articletitle","label":"Article Title"},{"value":"Respiratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resinv.2025.07.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V. on behalf of The Japanese Respiratory Society.","name":"copyright","label":"Copyright"}]}}